Predictive analytics offer huge potential value to healthcare organizations — but only if you pick the right problems to solve
Arcadia and Castell Health’s partnership is more than just a transaction. In the quest for better patient outcomes, both parties share a commitment to challenging the status quo.
New FDA guidance highlights how crucial it is to have a vetting process that ensures data suppliers meet your data quality needs. As you collaborate with RWD suppliers, here are three critical questions to ask.
Meghan Tortora is paid to sweat the small stuff. After all, she’s Director of Network Quality at Beth Israel Lahey, a network of 13 hospitals with over one million individual patients. These many profiles present a dizzying data challenge, and Arcadia stepped up to gather, organize, and analyze.
Arcadia Vice President of Enterprise Partnerships, Anna Basevich, recently spoke with IMSNY CIO, Elise Kohl-Grant, about the lack of technology investment in behavioral health, how standardized data could open doors for new patient benefits, and why technology can lead to significant positive outcomes for the whole person care.
Arcadia Chief Product Officer, Nick Stepro and Castell Medical Director and Interim COO, Dr. Will Daines, discuss realigning payers and medical providers around mutual benefits value-based care, the technology needed to deploy that change, and the outcomes that it delivers to patients, providers, and payers.
Vaccination is likely protective against long-COVID, even if vaccination occurs up to 12 weeks after COVID-19 diagnosis
Arcadia just released a new study showing that getting vaccinated for COVID-19 reduces the incidence and severity of long-COVID. Here, we explain the research and findings.
Health equity, reaching vulnerable populations, and keeping up with changes in the way healthcare is delivered. Here's Rush Health President and Executive Director Anthony Del Rio's perspective on how providers and the health systems they work within are rising to meet these enormous challenges.
Arcadia Vice President of Enterprise Partnerships, Anna Basevich, and KLAS Research Director, Bradley Hunter, discuss shifts in the marketplace and how more providers can access the benefits of at-risk models through key strategic initiatives.